Olive is losing some of its top talent, three sources familiar with the matter tell Axios.
Why it matters: Valued at $4 billion by leading firms including Tiger Global and General Catalyst, Olive is the venture darling of health care automation — a process intended to cut costs and put more resources toward patient care.
